Tags

Type your tag names separated by a space and hit enter

Evaluation of antimicrobial activity of beta-lactam antibiotics using Etest against clinical isolates from 60 medical centres in Japan.
Int J Antimicrob Agents. 2005 Apr; 25(4):296-301.IJ

Abstract

An antimicrobial resistance surveillance study was carried out in 60 medical centres across Japan. Resistance to piperacillin was 10.8% in clinical isolates of Escherichia coli, while 1.3% or fewer isolates were resistant to other beta-lactams. Klebsiella spp. were more susceptible to imipenem, cefepime and cefpirome. Isolates of Enterobacter spp., Citrobacter spp., indole-positive Proteus and Serratia spp. were susceptible to imipenem, cefepime and cefpirome, while Acinetobacter spp. were most susceptible to cefoperazone/sulbactam, imipenem, ceftazidime (5.8% resistance) and cefepime (7.6%). Isolates of Pseudomonas aeruginosa were more susceptible to ceftazidime (12.3% resistance), cefoperazone/sulbactam (12.5%) and cefepime (12.6%) than to piperacillin (15.0%), cefpirome (22.6%) and imipenem (30.8%). The percentage of Japanese imipenem resistant P. aeruginosa clinical isolates was around 30%.

Authors+Show Affiliations

Department of Microbiology, Toho University School of Medicine, 5-21-16 Omori-nishi, Ota-ku, 1438540 Tokyo, Japan. yoishii@med.toho-u.ac.jpNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

15784308

Citation

Ishii, Yoshikazu, et al. "Evaluation of Antimicrobial Activity of Beta-lactam Antibiotics Using Etest Against Clinical Isolates From 60 Medical Centres in Japan." International Journal of Antimicrobial Agents, vol. 25, no. 4, 2005, pp. 296-301.
Ishii Y, Alba J, Kimura S, et al. Evaluation of antimicrobial activity of beta-lactam antibiotics using Etest against clinical isolates from 60 medical centres in Japan. Int J Antimicrob Agents. 2005;25(4):296-301.
Ishii, Y., Alba, J., Kimura, S., Shiroto, K., & Yamaguchi, K. (2005). Evaluation of antimicrobial activity of beta-lactam antibiotics using Etest against clinical isolates from 60 medical centres in Japan. International Journal of Antimicrobial Agents, 25(4), 296-301.
Ishii Y, et al. Evaluation of Antimicrobial Activity of Beta-lactam Antibiotics Using Etest Against Clinical Isolates From 60 Medical Centres in Japan. Int J Antimicrob Agents. 2005;25(4):296-301. PubMed PMID: 15784308.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Evaluation of antimicrobial activity of beta-lactam antibiotics using Etest against clinical isolates from 60 medical centres in Japan. AU - Ishii,Yoshikazu, AU - Alba,Jimena, AU - Kimura,Soichiro, AU - Shiroto,Katsuaki, AU - Yamaguchi,Keizo, PY - 2004/09/14/received PY - 2004/12/17/accepted PY - 2005/3/24/pubmed PY - 2005/7/22/medline PY - 2005/3/24/entrez SP - 296 EP - 301 JF - International journal of antimicrobial agents JO - Int J Antimicrob Agents VL - 25 IS - 4 N2 - An antimicrobial resistance surveillance study was carried out in 60 medical centres across Japan. Resistance to piperacillin was 10.8% in clinical isolates of Escherichia coli, while 1.3% or fewer isolates were resistant to other beta-lactams. Klebsiella spp. were more susceptible to imipenem, cefepime and cefpirome. Isolates of Enterobacter spp., Citrobacter spp., indole-positive Proteus and Serratia spp. were susceptible to imipenem, cefepime and cefpirome, while Acinetobacter spp. were most susceptible to cefoperazone/sulbactam, imipenem, ceftazidime (5.8% resistance) and cefepime (7.6%). Isolates of Pseudomonas aeruginosa were more susceptible to ceftazidime (12.3% resistance), cefoperazone/sulbactam (12.5%) and cefepime (12.6%) than to piperacillin (15.0%), cefpirome (22.6%) and imipenem (30.8%). The percentage of Japanese imipenem resistant P. aeruginosa clinical isolates was around 30%. SN - 0924-8579 UR - https://www.unboundmedicine.com/medline/citation/15784308/Evaluation_of_antimicrobial_activity_of_beta_lactam_antibiotics_using_Etest_against_clinical_isolates_from_60_medical_centres_in_Japan_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0924-8579(05)00029-4 DB - PRIME DP - Unbound Medicine ER -